如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Kurtoxin (0.1mg vial)
產(chǎn)品型號(hào): PKT-4375-s
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Kurtoxin (0.1mg vial)
Kurtoxin (0.1mg vial)
的詳細(xì)介紹
- Product Code: PKT-4375-s
- Synonyms/Product Alternate Names: Lys-Ile-Asp-Gly-Tyr-Pro-Val-Asp-Tyr-Trp-Asn-Cys-Lys-Arg-Ile-Cys-Trp-Tyr-Asn-Asn-Lys-Tyr-Cys-Asn-Asp-Leu-Cys-Lys-Gly-Leu-Lys-Ala-Asp-Ser-Gly-Tyr-Cys-Trp-Gly-Trp-Thr-Leu-Ser-Cys-Tyr-Cys-Gln-Gly-Leu-Pro-Asp-Asn-Ala-Arg-Ile-Lys-Arg-Ser-Gly-Arg-Cys-Arg-Ala
- T-type Ca2+ Channel Blocker
- Origin: (Scorpion, Parabuthus transvaalicus)
- Storage Conditions: -20 °C
- Molecular Weight: 7386.4
- Molecular Formula: C324H478N94O90S8
- Disulfide Bonds: (Disulfide bonds between Cys12-Cys61Cys16-Cys37, Cys23-Cys44, and Cys27-Cys46)
R.S-I. Chuang, H. Jaffe, L. Cribbs, E. Perez-Reyes, and K.J. Swartz, Nat. Neurosci., 1, 668 (1998). (Original)
S.S. Sidach and I.M. Mintz, J. Neurosci., 22, 2023 (2002). (Pharmacol.; Specificity for Ca<sup>2+</sup> Channel Blocking Activity)
T. Olamendi-Portugal, B.I. Garcá, I. López-González, J. Van Der Walt, K. Dyason, C. Ulens, J. Tytgat, R. Felix, A. Darszon, and L.D. Possani, Biochem. Biophys. Res. Commun., 299, 562 (2002). (Pharmacol.)
I. López-González, T. Olamendi-Portugal, J.L. De La Vega-Beltrán, J. Van der Walt, K. Dyason, L.D. Possani, R. Felix, and A. Darszon, Biochem. Biophys. Res. Commun., 300, 408 (2003). (Pharmacol.)
H. Nishio, Y. Nishiuchi, M. Ishimaru, and T. Kimura, Lett. Pept. Sci., in press. (Chem. Synthesis & S-S Bond)
